OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer - Aghajanian, C; Blank, S V; Goff, B A (J Clin Oncol, 2012)
et al.